Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.
暂无分享,去创建一个
[1] M. Knowles. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? , 2006, Carcinogenesis.
[2] Liang Cheng,et al. Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder , 2006, Clinical Cancer Research.
[3] J. Machiels,et al. A single arm, multicenter, open label, phase II study of lapatinib as 2L treatment of pts with locally advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract , 2005 .
[4] T. Tzai,et al. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder , 2005, British Journal of Cancer.
[5] A. Ullrich,et al. EGFR signal transactivation in cancer cells. , 2003, Biochemical Society transactions.
[6] B. Peace,et al. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor. , 2003, Experimental cell research.
[7] E. Leonard,et al. Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors. , 2001, Histology and histopathology.
[8] M. Cilli,et al. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the ron receptor , 1998, Oncogene.